Juno Therapeutics Technical Analysis

    Juno Therapeutics Inc -- USA Stock  

    USD 86.96  0.01  0.0115%

    Juno Therapeutics Inc retains Coefficient Of Variation of 634.8, Market Risk Adjusted Performance of 0.4798 and Risk Adjusted Performance of 0.1575. Juno Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found eighteen technical drivers for Juno Therapeutics Inc which can be compared to its competitors. Please check out Juno Therapeutics Inc Variance, Value At Risk as well as the relationship between Value At Risk and Skewness to decide if Juno Therapeutics is priced fairly providing market reflects its last-minute price of 86.96 per share. Given that Juno Therapeutics Inc has Treynor Ratio of 0.4698, we strongly advise you confirm Juno Therapeutics Inc regular market performance to make sure the company can sustain itself at future point.
     Time Horizon     30 Days    Login   to change

    Juno Therapeutics Inc Technical Analysis

    Time Period
      Portfolio Suggestion  Portfolio Suggestion  
    Execute Indicator
    We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

    Juno Therapeutics Inc Trend Analysis

    Use this graph to draw trend lines for Juno Therapeutics Inc. You can use it to identify possible trend reversals for Juno Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Juno Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

    Juno Therapeutics Best Fit Change Line

    The following chart estimates an ordinary least squares regression model for Juno Therapeutics Inc applied against its price change over selected period. The best fit line has a slop of 0.098922 % which means Juno Therapeutics Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 7.98, which is the sum of squared deviations for the predicted Juno Therapeutics price change compared to its average price change.

    Did you try this?

    Run Equity Forecasting Now

    Equity Forecasting

    Use basic forecasting models to generate price predictions and determine price momentum
    Hide  View All  NextLaunch Equity Forecasting
    Juno Therapeutics Inc is rated below average in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about  1.84  of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Juno Therapeutics Inc is roughly  1.84 

    Juno Therapeutics Market Strength

    Juno Therapeutics March 21, 2018 Daily Price Condition